OCX insider trading
OncoCyte Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
OCX insider activity at a glance
FilingIQ has scored 210 insider transactions for OCX since Feb 16, 2016. The most recent filing in our index is dated Feb 7, 2025.
Across the full history, 109 open-market purchases
and 12 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on OCX insider trades is 54.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest OCX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Frequently asked
- How many insider trades does FilingIQ track for OCX?
- FilingIQ tracks 210 Form 4 insider transactions for OCX (OncoCyte Corp), covering filings from Feb 16, 2016 onwards. 0 of those were filed in the last 90 days.
- Are OCX insiders net buyers or net sellers?
- Across the full Form 4 history for OCX, 109 transactions (52%) were open-market purchases and 12 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does OCX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
Methodology & sources
Every OCX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.